On ECHEMI
Home > Drugs > Nimustine hydrochloride

Nimustine hydrochloride

Indication

Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.

Manufacturer

Fresenius Kabi (Wuhan) Pharmaceutical Co., Ltd.

  • Founded in:

    2012-07-20
  • Address:

    Biomedical Park, No. 858 Gaoxin Avenue, Wuhan East Lake New Technology Development Zone (Wuhan Area of Free Trade Zone)
  • Tax NO.:

    914201005979383918
  • Registered Funds:

    230 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.